Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England
- 1 March 2008
- journal article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 101 (3) , 139-143
Abstract
Summary Background: Analysis of primary healthcare datasets offers the possibility to increase understanding of the epidemiology of acute uncommon conditions such as anaphylaxis, but these datasets remain under-exploited. Aim: To investigate recent trends in the recorded incidence, lifetime prevalence and prescribing of adrenaline for anaphylaxis in England. Methods: QRESEARCH is one of the world's largest national aggregated health databases containing the records of over nine million patients. We extracted data on all patients with a recorded diagnosis of anaphylaxis and calculated annual age-sex standardized incidence and lifetime period prevalence rates for each year from 2001–2005. We also analysed trends in adrenaline prescribing in those with a recorded diagnosis of anaphylaxis. National population figures were used to estimate numbers of people in England that have experienced anaphylaxis at some point in their lives. Results: The age-sex standardized incidence of anaphylaxis was 6.7 per 100,000 person-years in 2001 and increased by 19% to 7.9 in 2005. Lifetime age-sex standardized prevalence of a recorded diagnosis of anaphylaxis was 50.0 per 100,000 in 2001 and increased by 51% to 75.5 in 2005. Prescribing of adrenaline increased by 97% over this period. By the end of 2005 there were an estimated 37,800 people that had experienced anaphylaxis at some point in their lives. Conclusions: Recorded incidence, lifetime prevalence and prescribing of adrenaline for anaphylaxis all showed substantial increases in recent years. An estimated 1 in 1,333 of the English population have at some point in their lives experienced anaphylaxis.Keywords
This publication has 12 references indexed in Scilit:
- Time trends in allergic disorders in the UKThorax, 2007
- Exploiting the potential of routine data to better understand the disease burden posed by allergic disordersClinical & Experimental Allergy, 2006
- Burden of allergic disease in the UK: secondary analyses of national databasesClinical & Experimental Allergy, 2004
- Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organizationJournal of Allergy and Clinical Immunology, 2004
- Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions dataBMJ, 2003
- Managing anaphylaxis: effective emergency and long‐term care are necessaryClinical & Experimental Allergy, 2003
- Anaphylaxis: risk factors for recurrenceClinical & Experimental Allergy, 2003
- Age, sex, geographical and socio‐economic variations in admissions for anaphylaxis: analysis of four years of English hospital data.Clinical & Experimental Allergy, 2001
- Hospital admissions for acute anaphylaxis: time trend studyBMJ, 2000
- The incidence, aetiology and management of anaphylaxis presenting to an Accident and Emergency departmentmxQJM: An International Journal of Medicine, 1996